Â鶹ѧÉú¾«Æ·°æ

Amiko M. Uchida
( out of 40 reviews )

Amiko M. Uchida, MD

Languages spoken: English

Clinical Locations

Gastroenterology /GI Clinic UUH

Gastroenterology, Area E
Salt Lake City
801-213-9797

  • CLINICAL:

    Amiko Uchida, MD is a gastroenterologist at the University of Utah School of Medicine and specializes in caring for and conducting research focused on patients with immune disorders of the GI tract, such as eosinophilic GI disease (EGID) and inflammatory bowel diseases (IBD). Dr. Uchida is a Utah-native and obtained her medical degree from the University of Utah before going on to train in internal medicine at the University of Washington and gastroenterology at Massachusetts General Hospital, where she also completed EGID and IBD training.

    She has particular interest and expertise in the increasingly common, yet poorly understood disease called eosinophilic esophagitis (EoE) as well as other eosinophilic gastrointestinal diseases. She is the Co-Director of the University of Utah Multidisciplinary Eosinophilic Gastrointestinal Disease Clinic, which is one of approximately five clinics of its type in the United States.

    Dr. Uchida’s other academic interests include the advancement of women in medicine and science and physician well-being and heads the Women in Gastroenterology Council. In her free time, she loves spending time in the great outdoors with her family. They particularly enjoy hiking, biking, and skiing.

    RESEARCH:

    Amiko Uchida, MD is a basic and translational physician-scientist gastroenterologist at the University of Utah School of Medicine where she also obtained her medical degree. She trained in gastroenterology at Massachusetts General Hospital and completed her post-doctoral work in the laboratories of John Garber MD and Stephanie and Michael Dougan, PhD and MD PhD, respectively. Dr. Uchida’s clinical and research interests include immune disorders of the GI tract, such as eosinophilic GI diseases and inflammatory bowel diseases. In addition to being co-Clinical Director of the Eosinophilic GI Disease Clinic, she is the Director of the Gastrointestinal Biobank, which connects basic scientists with clinicians and patient biospecimens to better understand health and disease.

    She currently working with co-mentor and Kathryn Peterson, MD MSCI investigating the increasingly common, yet poorly understood disease called eosinophilic esophagitis (EoE) and other EGIDs. She focuses on signaling mechanisms of disease pathology, the microbiota, and therapeutic options for patients suffering from EoE. More specifically, her research program encompasses better defining how diet and the microbiome affect inflammation in EoE and what non-invasive markers or testing can be performed to manage the disease.

    Please navigate to the Clinical Trials tab for some of the research opportunities as a part of our growing program.

    Specialties

    Board Certification

    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Gastroenterology)

    Patient Rating

    4.9 /5
    ( out of 40 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    June 24, 2025
    UNIVERSITY HOSPITAL

    Dr. Uchida is a shining light in the Gastroenterology realm of medicine. She truly enjoys her job which translates into more meaningful patient communication and treatment. I've been plagued with a myriad of GI problems for almost two decades but since being under her care I'm far more optimistic about my prognosis and symptom management.

    June 08, 2025
    UNIVERSITY HOSPITAL

    I felt that she listened to my concerns and left me with hope about my condition.

    April 11, 2025
    UNIVERSITY HOSPITAL

    One of the best providers I have ever seen.

    April 06, 2025
    UNIVERSITY HOSPITAL

    She's good doctor andl feel great full when she explained my problem, and give me fun situations, she's very active and fun

    February 21, 2025
    UNIVERSITY HOSPITAL

    Excellent nurse with a lot of knowledge [TRANSLATED]

    January 17, 2025
    UNIVERSITY HOSPITAL

    A GREAT DR! I WISHED I COULD SEE HER FOR ALL OF MY ISSUES!

    November 18, 2024
    UH HOSPITALS AND CLINICS

    Awesome care

    October 18, 2024
    UH HOSPITALS AND CLINICS

    Dr. Uchida always is so good to take her time and answer every single question I have. Explains everything and can tell she truly wants the best for each of her patients & will look into any solution to get me the care I need. I have loved her as my doctor!

    September 20, 2024
    UH HOSPITALS AND CLINICS

    Dr. Uchida was warm and receptive. In spite of what was probably a very busy day of seeing patients, Dr. Uchida took time to listen and address my concerns. She wanted my feedback when it came to discuss treatment options, which give me more confidence in the care I'm receiving.

    See More Patient Comments

  • CLINICAL:

    Amiko Uchida, MD is a gastroenterologist at the University of Utah School of Medicine and specializes in caring for and conducting research focused on patients with immune disorders of the GI tract, such as eosinophilic GI disease (EGID) and inflammatory bowel diseases (IBD). Dr. Uchida is a Utah-native and obtained her medical degree from the University of Utah before going on to train in internal medicine at the University of Washington and gastroenterology at Massachusetts General Hospital, where she also completed EGID and IBD training.

    She has particular interest and expertise in the increasingly common, yet poorly understood disease called eosinophilic esophagitis (EoE) as well as other eosinophilic gastrointestinal diseases. She is the Co-Director of the University of Utah Multidisciplinary Eosinophilic Gastrointestinal Disease Clinic, which is one of approximately five clinics of its type in the United States.

    Dr. Uchida’s other academic interests include the advancement of women in medicine and science and physician well-being and heads the Women in Gastroenterology Council. In her free time, she loves spending time in the great outdoors with her family. They particularly enjoy hiking, biking, and skiing.

    RESEARCH:

    Amiko Uchida, MD is a basic and translational physician-scientist gastroenterologist at the University of Utah School of Medicine where she also obtained her medical degree. She trained in gastroenterology at Massachusetts General Hospital and completed her post-doctoral work in the laboratories of John Garber MD and Stephanie and Michael Dougan, PhD and MD PhD, respectively. Dr. Uchida’s clinical and research interests include immune disorders of the GI tract, such as eosinophilic GI diseases and inflammatory bowel diseases. In addition to being co-Clinical Director of the Eosinophilic GI Disease Clinic, she is the Director of the Gastrointestinal Biobank, which connects basic scientists with clinicians and patient biospecimens to better understand health and disease.

    She currently working with co-mentor and Kathryn Peterson, MD MSCI investigating the increasingly common, yet poorly understood disease called eosinophilic esophagitis (EoE) and other EGIDs. She focuses on signaling mechanisms of disease pathology, the microbiota, and therapeutic options for patients suffering from EoE. More specifically, her research program encompasses better defining how diet and the microbiome affect inflammation in EoE and what non-invasive markers or testing can be performed to manage the disease.

    Please navigate to the Clinical Trials tab for some of the research opportunities as a part of our growing program.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Assistant Professor
    Pathology -Adjunct Assistant Professor
    Academic Divisions Gastroenterology
    Board Certification
    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Gastroenterology)

    Education history

    Fellowship Eosinophilic Esophagitis and Inflammatory Bowel Disease - Massachusetts General Hospital Advanced Fellow
    Fellowship Gastroenterology - Massachusetts General Hospital Fellow
    Residency Internal Medicine - University of Washington Intern/Resident
    Professional Medical Medicine - University of Utah School of Medicine M.D.
    Undergraduate Major: Zoology; Minor: Chemistry - Weber State University B.S.

    Selected Publications

    Journal Article

    1. Olsson N, Bergman D, Sun J, Carlson M, Uchida AM, Ludvigsson JF (2025). Incidence of non-esophageal eosinophilic gastrointestinal disease in Sweden 1990-2015. Scand J Gastroenterol, 60(4), 343-348. ()
    2. Turapov T, Uchida AM, Pletneva MA, Peterson KA (2025). Gastrointestinal Tissue Eosinophil Quantification in Healthy Adult Volunteers. Gastroenterology, 169(1), 158-160.e2. ()
    3. Pyne AL, Uchida AM, Hazel MW, Pletneva MA, Allen-Brady K, Peterson KA (2024). Differing Epithelial and Immunologic Activation Patterns Following Food Reintroduction Reveal Different Transcriptional Profiles in Active Eosinophilic Esophagitis. Gastroenterology, 168(3), 598-600.e3. ()
    4. Benjamin L Wright, MD12, Juan Pablo Abonia, MD3, Edsel M Abud, MD, PhD45, Seema S Aceves, MD, PhD5, Steven J Ackerman, PhD6, Melinda Braskett, MD7, Joy W Chang, MD, MS8, Mirna Chehade, MD, MPH9, Gregory M Constantine, MD10, Carla M Davis, MD11, Evan S Dellon, MD, MPH12, Alfred D Doyle, PhD1, Raquel Durban, RD13, David A Hill MDPhD14, 15, Elizabeth T Jensen, MPH, PhD16, Anupama Kewalramani, MD17, Paneez Khoury, MD, MHSc10, Amy D Klion, MD10, Leah Kottyan, PhD3, Fei Li Kuang, MD, PhD18 Emily C McGowan, MD, PhD19, Melanie A Ruffner MD, PhD1415, Lisa A Spencer, PhD20, Jonathan M Spergel, MD, PhD1415, Amiko M Uchida, MD21, Joshua B Wechsler, MD, MSc22, Robert D Pesek, MD23 (2024). Advances and Ongoing Challenges in Eosinophilic Gastrointestinal Disorders presented at the CEGIR/TIGERS Symposium at the 2024 American Academy of Allergy, Asthma, & Immunology Meeting. . JACI.
    5. Pyne AL, Uchida AM, Hazel MW, Stubben CJ, Chang JW, Bailey DD, Gonsalves N, Allen-Brady K, Peterson KA, Pletneva MA (2024). Effect of benralizumab on histopathology and inflammatory signatures in a clinical cohort of eosinophilic esophagitis. Dis Esophagus. ()
    6. Forss A, Uchida AM, Roelstraete B, Ebrahimi F, Garber JJ, Sundstrm J, Ludvigsson JF (2024). Eosinophilic esophagitis and risk of incident major adverse cardiovascular events: a nationwide matched cohort study. Esophagus. ()
    7. Bozorg SR, Sderling J, Mrild K, Garber JJ, Uchida A, Neovius M, Ludvigsson JF, Everhov H (2024). Economic Burden of Eosinophilic Esophagitis: A Nationwide Cost-of-Illness Study. Am J Gastroenterol. ()
    8. Ding J, Garber JJ, Uchida A, Lefkovith A, Carter GT, Vimalathas P, Canha L, Dougan M, Staller K, Yarze J, Delorey TM, Rozenblatt-Rosen O, Ashenberg O, Graham DB, Deguine J, Regev A, Xavier RJ (2024). An esophagus cell atlas reveals dynamic rewiring during active eosinophilic esophagitis and remission. Nat Commun, 12(1), 3344.
    9. Ding J, Garber JJ, Uchida A, Lefkovith A, Carter GT, Vimalathas P, Canha L, Dougan M, Staller K, Yarze J, Delorey TM, Rozenblatt-Rosen O, Ashenberg O, Graham DB, Deguine J, Regev A, Xavier RJ (2024). An esophagus cell atlas reveals dynamic rewiring during active eosinophilic esophagitis and remission. Nat Commun, 15(1), 3344. ()
    10. Soni M, Peterson KA, Uchida AM (2024). Eosinophilic Gastrointestinal Diseases. JAMA.
    11. Uchida AM (2023). "Eosinophilic esophagitis is associated with increased risk of later inflammatory bowel disease in a nationwide Swedish population cohort. United European Gastroenterology Journal, 12(1), 34-43.
    12. Reddy CA, Allen-Brady K, Uchida AM, Peterson KA, Hoffman AM, Souza RF, Spechler SJ (2023). Achalasia is Strongly Associated with Eosinophilic Esophagitis and Other Allergic Disorders. Clin Gastroenterol Hepatol, 22(1), 34-41.e2. ()
    13. Warner ASC, Ufere NN, Patel NJ, Lau ES, Uchida AM, Hills-Dunlap K, Bromberg GK, Cunningham EA, Tagerman MD, Mills GG, Palamara K, Rigotti NA, Burnett-Bowie SM, Yeh DD, Tanguturi VK (2022). A Women in Medicine Trainees' Council: a model for women trainee professional development. Postgrad Med J, 99(1168), 79-82. ()
    14. Lopes EW, Boneschansker L, Chu JN, Ha JB, Badran YR, McLean Diaz P, Przybyszewski EM, Scheid JF, Subramanian S, Vlez C, Wilechansky RM, Changela M, Richter JM, Uchida AM, Lochhead P (2023). Improving the Consent Process With an Informed Consent Video Prior to Outpatient Colonoscopy. Gastro Hep Adv, 2(8), 1082-1087. ()
    15. Uchida AM, Ro G, Garber JJ, Roelstraete B, Ludvigsson JF (2022). Prior hospital-based infection and risk of eosinophilic esophagitis in a Swedish nationwide case-control study. United European Gastroenterol J, 10(9), 999-1007. ()
    16. Uchida, AM, Ro, G, Garber, JJ, Roelstraete, B, Ludvigsson, JF (2022). Prior hopsital-based infection and risk of eosinophilic esophagitis in a Swedish nationwide case-control study. United European Gastroenterol J, 1-9.
    17. Allen-Brady K, Colletier KJ, Woller S, Eliason K, Uchida AM, Ro G, Newman M, Peterson KA (2022). Eosinophilic Gastritis and Enteritis Are Increased in Families with Eosinophilic Esophagitis. Am J Gastroenterol, 118(2), 263-268. ()
    18. Pyne AL, Hazel MW, Uchida AM, Qeadan F, Jordan KC, Holman A, Harward B, Gleich GJ, Peterson KA (2022). Oesophageal secretions reveal local food-specific antibody responses in eosinophilic oesophagitis. Aliment Pharmacol Ther, 56(9), 1328-1336. ()
    19. Uchida AM, Ro G, Qiang L, Peterson KA, Round J, Dougan M, Dougan SK (2022). Human differentiated eosinophils release IL-13 in response to IL-33 stimulation. Front Immunol, 13, 946643. ()
    20. Kummerlowe C, Mwakamui S, Hughes TK, Mulugeta N, Mudenda V, Besa E, Zyambo K, Shay JES, Fleming I, Vukovic M, Doran BA, Aicher TP, Wadsworth MH 2nd, Bramante JT, Uchida AM, Fardoos R, Asowata OE, Herbert N, Yilmaz H, Klverpris HN, Garber JJ, Ordovas-Montaes J, Gartner ZJ, Wallach T, Shalek AK, Kelly P (2022). Single-cell profiling of environmental enteropathy reveals signatures of epithelial remodeling and immune activation. Sci Transl Med, 14(660), eabi8633. ()
    21. Garber JJ, Roelstraete B, Lochhead PJ, Uchida AM, Michalsson K, Oln O, Ludvigsson JF (2022). Risk of fractures in individuals with eosinophilic esophagitis: nationwide population-based cohort study. Esophagus. ()
    22. Garber JJ, Lochhead PJ, Uchida AM, Roelstraete B, Bergman D, Clements MS, Ludvigsson JF (2022). Increasing incidence of eosinophilic esophagitis in Sweden: a nationwide population study. Esophagus. ()
    23. Lenehan PJ, Cirella A, Uchida AM, Crowley SJ, Sharova T, Boland G, Dougan M, Dougan SK, Heckler M (2021). Type 2 immunity is maintained during cancer-associated adipose tissue wasting. Immunother Adv, 1(1), ltab011. ()
    24. Przybyszewski EM, Deshpande V, Uchida AM (2020). An Unsuspected Cause of Rectal Bleeding. Gastroenterology, 160(4), e1-e2. ()
    25. Kumar NL, Kugener G, Vemula A, Wasan S, Uchida AM, Scheid FJ, Yarze J, Saltzman JR (2020). Multi-center prospective validation study of the SAFE-T colonoscopy evaluation tool: a web-based smartphone application for evaluation of gastroenterology fellow performance in colonoscopy. Gastroenterol Rep (Oxf).
    26. Uchida AM, Boden EK, James EA, Shows DM, Konecny AJ, Lord JD (2020). Escherichiacoli-Specific CD4+ T Cells Have Public T-Cell Receptors and Low Interleukin 10 Production in Crohn's Disease. Cell Mol Gastroenterol Hepatol, 10(3), 507-526. ()
    27. Chou DB, Sworder B, Bouladoux N, Roy CN, Uchida AM, Grigg M, Robey PG, Belkaid Y (2012). Stromal-derived IL-6 alters the balance of myeloerythroid progenitors during Toxoplasma gondii infection. J Leukoc Biol, 92(1), 123-31. ()
    28. Uchida AM, Meyers RA, Cooper BG, Goller F (2010). Fibre architecture and song activation rates of syringeal muscles are not lateralized in the European starling. J Exp Biol, 213(Pt 7), 1069-78. ()

    Review

    1. Uchida AM, Burk CM, Rothenberg ME, Furuta GT, Spergel JM (2023). Recent advances in the treatment of eosinophilic esophagitis. [Review]. J Allergy Clin Immunol Pract, 11(9), 2654-2663.
    2. Uchida AM, Ro G, Garber JJ, Peterson KA, Round JL (2022). Models and Tools for Investigating Eosinophilic Esophagitis at the Bench. [Review]. Front Immunol, 13, 943518. ()

    Editorial

    1. Uchida AM, Dougan M (2021). Editorial: Penetration of food protein through the oesophageal mucosa-is this where EoE starts? Aliment Pharmacol Ther, 53(3), 447-448. ()

    Letter

    1. Spechler SJ, Reddy CA, Allen-Brady K, Uchida AM, Peterson KA, Hoffman AM, Souza RF (2023). Reply. [Letter to the editor]. Clin Gastroenterol Hepatol. ()
    2. Uchida AM, Rabinowitz LG, Harris CE, Clark VR, Duma N, Willers H (2021). Baby Steps in the Right Direction: Toward a Parental Leave Policy for Gastroenterology Fellows. [Letter to the editor]. Am J Gastroenterol, 116(11), 2300. ()
    3. Uchida AM, Lenehan PJ, Vimalathas P, Miller KC, Valencia-Yang M, Qiang L, Canha LA, Ali LR, Dougan M, Garber JJ, Dougan SK (2021). Tissue eosinophils express the IL-33 receptor ST2 and type 2 cytokines in patients with eosinophilic esophagitis. [Letter to the editor]. Allergy, 77, 656-660. ()
    4. Harris CE, Clark VR, Duma N, Uchida AM, Kowalski A (2021). Re: "The Intersection of Disability and Pregnancy: Risks for Maternal Morbidity and Mortality" by Signore et al. [Letter to the editor]. J Womens Health (Larchmt), 30(9), 1362-1363. ()

    Abstract

    1. Uchida AM, Vimalalthas P, Valencia-Yang M, Miller K, Garber J (2020). The IL-33 receptor ST2 is highly induced on IL- 13-expressing tissue eosinophils in eosinophilic esophagitis [Abstract]. 145(2), 43.

  • News & Podcasts

    News